Literature DB >> 7774336

Regular beta-adrenergic agonists. Evidence, not reassurance, is what is needed.

D R Taylor1, M R Sears.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 7774336     DOI： 10.1378/chest.106.2.552

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  6 in total

1.  Case-control study of salmeterol and near-fatal attacks of asthma.

Authors:  C Williams; L Crossland; J Finnerty; J Crane; S Holgate; N Pearce; R Beasley
Journal:  Thorax       Date:  1998-01       Impact factor: 9.139

Review 2.  Asthma and the beta agonist debate.

Authors:  J Crane; N Pearce; C Burgess; R Beasley
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

Review 3.  Tolerance with beta 2-adrenoceptor agonists: time for reappraisal.

Authors:  A Grove; B J Lipworth
Journal:  Br J Clin Pharmacol       Date:  1995-02       Impact factor: 4.335

4.  Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol.

Authors:  D R Taylor; G I Town; G P Herbison; D Boothman-Burrell; E M Flannery; B Hancox; E Harré; K Laubscher; V Linscott; C M Ramsay; G Richards
Journal:  Thorax       Date:  1998-09       Impact factor: 9.139

5.  Double blind randomised controlled trial of two different breathing techniques in the management of asthma.

Authors:  C A Slader; H K Reddel; L M Spencer; E G Belousova; C L Armour; S Z Bosnic-Anticevich; F C K Thien; C R Jenkins
Journal:  Thorax       Date:  2006-03-03       Impact factor: 9.139

Review 6.  The beta 2-agonist controversy. Observations, explanations and relationship to asthma epidemiology.

Authors:  M R Sears; D R Taylor
Journal:  Drug Saf       Date:  1994-10       Impact factor: 5.606
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.